![[Leu15]-Gastrin I (human)](https://file.medchemexpress.com/product_pic/hy-p2671.gif "Click to View [Leu15]-Gastrin I (human) Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
43 Results for "
gastrointestinal peptide
" in MedChemExpress (MCE) Product Catalog:
Products (43)
43 Results for "gastrointestinal peptide" in MCE Product Catalog:
3
3 Cited Publications
Cat. No.: HY-P0197
CAS No.: 86933-74-6
Synonyms: Substance K; Neurokinin α; Neuromedin L; NKA
Target:
Research Areas:
3
3 Cited Publications
Cat. No.: HY-P0197A
CAS No.: 2828433-19-6
Synonyms: Substance K TFA; Neurokinin α TFA; Neuromedin L TFA; NKA TFA
Target:
Research Areas:
2
2 Cited Publications
Synonyms: Cholecystokinin-33(human); CCK-33(human)
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P2671
CAS No.: 39024-57-2
Target:
Research Areas:
Cat. No.: HY-105174A
CAS No.: 1628202-19-6
Research Areas:
Synonyms: SK-1403; AJT240; PLS240
Target:
Research Areas:
Upacicalcet sodium is a non-peptide calcimimetic that acts as a CaSR agonist (EC50 = 10.8 nM). Upacicalcet sodium reduces serum intact parathyroid hormone (iPTH) and serum Ca 2+ levels, reducing hypocalcemia and gastrointestinal complications. Upacicalcet sodium sodium improves vascular calcification and bone disorders in the Adenine (HY-B0152)-induced secondary hyperparathyroidism (SHPT) rat model. Upacicalcet sodium sodium inhibits cortical pore formation and reduces bone fibrosis in rats with chronic kidney disease (CKD). Upacicalcet sodium is useful for studying SHPT .
Cat. No.: HY-P3622
CAS No.: 215777-46-1
Target:
Research Areas:
Cat. No.: HY-P4060
CAS No.: 59763-91-6
Target:
Research Areas:
Target:
Research Areas:
GLP-1R agonist 3 is a potent agonist of GLP-1R. GLP-1R agonist 3 is a thickened imidazole derivative compound. Glucagon-like peptide-1 (GLP-1) is an intestinal hypoglycemic hormone secreted by L-cells in the lower gastrointestinal tract. GLP-1R agonist 3 has the potential for the research of diabetes (extracted from patent WO2021197464A1, compound 1) .
Cat. No.: HY-P1179
CAS No.: 183200-12-6
Research Areas:
Cat. No.: HY-P1179A
Research Areas:
Cat. No.: HY-P1806A
Target:
Research Areas:
Cat. No.: HY-P1015
CAS No.: 96886-24-7
Synonyms: Vasoactive Intestinal peptide, guinea pig
Target:
Research Areas:
Cat. No.: HY-P1421
CAS No.: 1081110-72-6
Research Areas:
Target:
Research Areas:
GLP-1R agonist 4 is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is an intestinal hypoglycemic hormone secreted by L-cells in the lower gastrointestinal tract. GLP-1R agonist 4 can be used for the research of type 2 diabetes mellitus, obesity, non-alcoholic steatohepatitis, insulin resistance and etc .
Cat. No.: HY-P5429
CAS No.: 146064-85-9
Target:
Research Areas:
Cat. No.: HY-P5325A
Target:
Research Areas:
Cat. No.: HY-P5325
CAS No.: 505070-05-3
Target:
Research Areas:
Cat. No.: HY-P2703
CAS No.: 81858-94-8
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
